Insmed Inc (INSM)

[read_this_n0w]

and do not forget that trca bring a marketing team exactly in place at the right spot for them for the US market..
so the net investment is 68mln..
discounted by not having to put up their own specific sales team there..so overall net investment is even smaller..
they definately will make a profit on that, evne if increlex sales are a small portion of the market, will still generatesome revenue



"Ipsen invests maximum $123.6MM but gets in return max. $55MM from TRCA = a net investment of $68.6MM in TRCA. Apart from mutual income from sales. So Ipsen pays only for 400 guaranteed patients while being able to sell Increlex worldwide where approved. This brings TRCA a max of 55% of $28000/year = $13.5K/patient/year."